These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29330093)

  • 1. Designing improved active peptides for therapeutic approaches against infectious diseases.
    Gomes B; Augusto MT; Felício MR; Hollmann A; Franco OL; Gonçalves S; Santos NC
    Biotechnol Adv; 2018; 36(2):415-429. PubMed ID: 29330093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming biological peptides to combat infectious diseases.
    Der Torossian Torres M; de la Fuente-Nunez C
    Chem Commun (Camb); 2019 Dec; 55(100):15020-15032. PubMed ID: 31782426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic antimicrobial peptides as potential new therapeutic agents in neonates and children: a review.
    Ashby M; Petkova A; Hilpert K
    Curr Opin Infect Dis; 2014 Jun; 27(3):258-67. PubMed ID: 24722240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides.
    Ghosh C; Haldar J
    ChemMedChem; 2015 Oct; 10(10):1606-24. PubMed ID: 26386345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial peptides: an alternative for innovative medicines?
    da Costa JP; Cova M; Ferreira R; Vitorino R
    Appl Microbiol Biotechnol; 2015 Mar; 99(5):2023-40. PubMed ID: 25586583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured antimicrobial peptides: The last push towards clinics.
    Carratalá JV; Serna N; Villaverde A; Vázquez E; Ferrer-Miralles N
    Biotechnol Adv; 2020 Nov; 44():107603. PubMed ID: 32738381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antimicrobial peptides in host defense against mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2008 Oct; 29(10):1836-41. PubMed ID: 18582513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting eukaryotic anti-infective biotherapeutics.
    Rishi P; Singh AP; Arora S; Garg N; Kaur IP
    Crit Rev Microbiol; 2014 Nov; 40(4):281-92. PubMed ID: 23317462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial compounds of enterococci].
    Valyshev AV
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (5):119-26. PubMed ID: 25536783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides: therapeutic potentials.
    Kang SJ; Park SJ; Mishig-Ochir T; Lee BJ
    Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1477-86. PubMed ID: 25371141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors.
    Willers C; Wentzel JF; du Plessis LH; Gouws C; Hamman JH
    Expert Opin Ther Targets; 2017 Jan; 21(1):23-36. PubMed ID: 27892739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance.
    Nuti R; Goud NS; Saraswati AP; Alvala R; Alvala M
    Curr Med Chem; 2017; 24(38):4303-4314. PubMed ID: 28814242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of anti-infectives.
    Agarwal AK; Fishwick CW
    Ann N Y Acad Sci; 2010 Dec; 1213():20-45. PubMed ID: 21175675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide motifs for cell-surface intervention: application to anti-infective and biopharmaceutical development.
    Monk BC; Harding DR
    BioDrugs; 2005; 19(4):261-78. PubMed ID: 16128608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Dendrimeric Peptides: Structure, Activity and New Therapeutic Applications.
    Scorciapino MA; Serra I; Manzo G; Rinaldi AC
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial peptide mimics for improved therapeutic properties.
    Rotem S; Mor A
    Biochim Biophys Acta; 2009 Aug; 1788(8):1582-92. PubMed ID: 19028449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CyLoP-1: Membrane-active peptide with cell-penetrating and antimicrobial properties.
    Ponnappan N; Budagavi DP; Chugh A
    Biochim Biophys Acta Biomembr; 2017 Feb; 1859(2):167-176. PubMed ID: 27836642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic antimicrobial peptides - an update.
    Zhang L; Falla TJ
    Expert Opin Investig Drugs; 2004 Feb; 13(2):97-106. PubMed ID: 14996645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Péptidos antimicrobianos, una alternativa prometedora para el tratamiento de enfermedades infecciosas].
    Samael Olascoaga-Del AK; Sánchez-Evangelista G; Carmona-Navarrete I; Galicia-Sánchez MDC; Gómez-Luna A; Islas-Arrollo SJ; Castañeda-Sánchez JI
    Gac Med Mex; 2018; 154(6):681-688. PubMed ID: 30532100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Peptides and Innate Lung Defenses: Role in Infectious and Noninfectious Lung Diseases and Therapeutic Applications.
    Hiemstra PS; Amatngalim GD; van der Does AM; Taube C
    Chest; 2016 Feb; 149(2):545-551. PubMed ID: 26502035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.